Ocular Therapeutix™ to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held from September 13-15, 2021. In addition to the presentation, the management team will host virtual investor meetings. Investors participating in the conference